While our data demonstrate that non-canonical ATM activation was normal in human ASCIZ/ATMIN-knockout lymphoma cells (Fig. 4), we acknowledge that reduced ATM activation in response to aphidicolin treatment has recently been reported in human ASCIZ/ATMIN siRNA knockdown cell lines [10], [15]. This evidence concerns the gene ATMIN and lymphoma.